The Covid-19 pandemic emerged and consumed over half a million lives within 6 months. There has been an unprecedented response from the medical research community but dissemination of data has often occurred via media announcements and pre-prints without the usual checks of the peer review process. Has this served us well under the circumstances? Or should we do things differently in future?
- Home
- MEETINGS & EVENTS
- AoP WEBINAR SERIES: Emerging issues in medicine
- “Can evidence-based medicine survive in a pandemic?”
“Can evidence-based medicine survive in a pandemic?”
The Programme
| 17.00-17.05 | Setting the scene: introduction from the Secretary of the AoP (Co-Chair) Professor Christian Delles Secretary, Association of Physicians of Great Britain & Ireland Professor and Consultant Physician at the Institute for Cardiovascular and Medical Sciences, University of Glasgow Professor Alan Irvine (Co-Chair) Executive Committee Member, Association of Physicians of Great Britain & Ireland Professor in Dermatology, Trinity College Dublin |
| 17.05-17.10 | Immediate pandemic responses – history and behavioural perspectives Dr Ida Milne Pandemic Social Historian, Carlow College, Ireland |
| 17.10-17.15 | Prescription panic in a pandemic – prescribing in the USA in March /April 2020 Dr Haider Warriach Department of Medicine, VA Boston Healthcare System, Boston, Massachusetts |
| 17.15-17.25 | Measuring the immunological evidence in COVID-19 Professor Katja Simon and Mr Felix Richter Kennedy Institute of Rheumatology, University of Oxford Professor Awen Gallimore Cardiff University School of Medicine |
| 17.25-17.30 | Reporting the RECOVERY Trial Professor Peter Horby Nuffield Dept of Medicine, University of Oxford |
| 17.30-17.35 | Pre-prints – for good or ill? Mr Jonathan Schultz Director, Journal Operations, American Heart Association |
| 17.35-18.00 | Panel Discussion Discussant Professor Colin Dayan Professor of Clinical Diabetes and Metabolism, Cardiff University |